FRIULCHEM S.P.A.

FRIULCHEM S.P.A.

About

Company description

Friulchem is a private B2B, P2P chemical-pharmaceutical company dealing with research, development and production of original & generic pharmaceutical products for both human and veterinary fields. Thanks to its R&D attitude and its results in term of projects and patents in both veterinary and human fields, Friulchem is listed since 2008 among the laboratories and institutions highly qualified and recognized by the local government of Region Friuli Venezia Giulia.

Quick facts

Sales markets Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America
Primary business activity Manufacturer
Affiliated categories: Contract Manufacturing |Antibiotics More

Recently at

9 oct 2018

CPhI Worldwide 2018

9 - 11 October 2018 Madrid, Spain We were at stand 4K32 See our Exhibitor Profile   See full Exhibitor List

News about FRIULCHEM S.P.A.

RIFAXIMIN BY FRIULCHEM - AN INNOVATIVE AND HELPFUL PRODUCT

12 Oct 2017

RIFAXIMIN BY FRIULCHEM - AN INNOVATIVE AND HELPFUL PRODUCT

Friulchem S.p.A., a Vivaro, Italy-based contract development and manufacturing organization for innovator and generic pharmaceutical products for human and veterinary use, reports on manufacturing developments for rifaximin, an active pharmaceutical ingredient (API) used to treat travelers' diarrhea in adults and children 12-years of age and older. Rifaximin has also been evaluated for treating hepatic encephalopathy, infectious diarrhea, diverticular disease, and as an antibacterial prophylactic before colon surgery.

Rifaximin is a semi-synthetic product derived from fermentation and that shows many polymorphs, most of them are covered by patent (alpha-, beta-, gamma-, and delta-forms). The alpha-polymorph is the most active. It cannot be absorbed, so its intestinal action is local, according to information from Friulchem.

Read more
FRIULCHEM S.P.A.

Contact information

Address

Telephone

Website

View all contact information